Inflammatory cytokine production in tumor cells upon chemotherapy drug exposure or upon selection for drug resistance
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inflammatory cytokine production in tumor cells upon chemotherapy drug exposure or upon selection for drug resistance
Authors
Keywords
Cytokines, Cancer treatment, Toll-like receptors, Cancer chemotherapy, Breast tumors, Inflammation, Macrophages, Chemotherapeutic agents
Journal
PLoS One
Volume 12, Issue 9, Pages e0183662
Publisher
Public Library of Science (PLoS)
Online
2017-09-16
DOI
10.1371/journal.pone.0183662
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Role of TLR4 in Chemotherapy-Driven Metastasis
- (2015) S. Ran CANCER RESEARCH
- Vascular-targeted TNFα improves tumor blood vessel function and enhances antitumor immunity and chemotherapy in colorectal cancer
- (2015) Lan Lu et al. JOURNAL OF CONTROLLED RELEASE
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- Apicidin and Docetaxel Combination Treatment Drives CTCFL Expression and HMGB1 Release Acting as Potential Antitumor Immune Response Inducers in Metastatic Breast Cancer Cells
- (2015) Maria Buoncervello et al. NEOPLASIA
- Toll-like receptor 2/4 heterodimer mediates inflammatory injury in intracerebral hemorrhage
- (2014) Yan-Chun Wang et al. ANNALS OF NEUROLOGY
- Activation of TLR-4 to produce tumour necrosis factor-α in neuropathic pain caused by paclitaxel
- (2014) Z. Wu et al. EUROPEAN JOURNAL OF PAIN
- Primary Surgery or Interval Debulking for Advanced Epithelial Ovarian Cancer
- (2014) Algirdas Markauskas et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation
- (2013) K. De Filippo et al. BLOOD
- Membrane versus Soluble Isoforms of TNF-α Exert Opposing Effects on Tumor Growth and Survival of Tumor-Associated Myeloid Cells
- (2013) Shidrokh Ardestani et al. CANCER RESEARCH
- TLR4 Is a Novel Determinant of the Response to Paclitaxel in Breast Cancer
- (2013) S. Rajput et al. MOLECULAR CANCER THERAPEUTICS
- Targeting CXCR2 Enhances Chemotherapeutic Response, Inhibits Mammary Tumor Growth, Angiogenesis, and Lung Metastasis
- (2013) B. Sharma et al. MOLECULAR CANCER THERAPEUTICS
- Enhanced chemosensitization in multidrug-resistant human breast cancer cells by inhibition of IL-6 and IL-8 production
- (2012) Zhi Shi et al. BREAST CANCER RESEARCH AND TREATMENT
- A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
- (2012) Swarnali Acharyya et al. CELL
- Toll-like receptor 4 ligation confers chemoresistance to docetaxel on PC-3 human prostate cancer cells
- (2012) Yuntao Zhang et al. CELL BIOLOGY AND TOXICOLOGY
- Tumor Necrosis Factor-α Signaling in Macrophages
- (2012) Narayanan Parameswaran et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- Toll-like Receptor 2 Is Required for LPS-induced Toll-like Receptor 4 Signaling and Inhibition of Ion Transport in Renal Thick Ascending Limb
- (2012) David W. Good et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Distinct genetic alterations occur in ovarian tumor cells selected for combined resistance to carboplatin and docetaxel
- (2012) Stephen R Armstrong et al. Journal of Ovarian Research
- Autocrine production of interleukin-8 confers cisplatin and paclitaxel resistance in ovarian cancer cells
- (2011) Yue Wang et al. CYTOKINE
- Tumor necrosis factor alpha increases P-glycoprotein expression in a BME-UV in vitro model of mammary epithelial cells
- (2010) Mohammad M. Al-Bataineh et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- The chemokine CXCL1 induces proliferation in epithelial ovarian cancer cells by transactivation of the epidermal growth factor receptor
- (2010) Christine Bolitho et al. ENDOCRINE-RELATED CANCER
- Hypermethylation of the ABCB1 downstream gene promoter accompanies ABCB1 gene amplification and increased expression in docetaxel-resistant MCF-7 breast tumor cells
- (2010) Kerry Reed et al. Epigenetics
- TAK-242 (Resatorvid), a Small-Molecule Inhibitor of Toll-Like Receptor (TLR) 4 Signaling, Binds Selectively to TLR4 and Interferes with Interactions between TLR4 and Its Adaptor Molecules
- (2010) N. Matsunaga et al. MOLECULAR PHARMACOLOGY
- Adjuvant Docetaxel for High-Risk, Node-Negative Breast Cancer
- (2010) Miguel Martín et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathways for Cytokine Secretion
- (2010) Amanda C. Stanley et al. PHYSIOLOGY
- TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer
- (2009) M Szajnik et al. ONCOGENE
- Low Levels of Tumor Necrosis Factor Increase Tumor Growth by Inducing an Endothelial Phenotype of Monocytes Recruited to the Tumor Site
- (2008) B. Li et al. CANCER RESEARCH
- The Interleukin-8 Pathway in Cancer
- (2008) D. J.J. Waugh et al. CLINICAL CANCER RESEARCH
- Taxanes inhibit human TLR4 signaling by binding to MD-2
- (2008) Nuša Resman et al. FEBS LETTERS
- Paclitaxel Binding to Human and Murine MD-2
- (2008) Shanta M. Zimmer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effect of Interleukin-8 Gene Silencing With Liposome-Encapsulated Small Interfering RNA on Ovarian Cancer Cell Growth
- (2008) William M. Merritt et al. JNCI-Journal of the National Cancer Institute
- TNF-mediated inflammatory disease
- (2007) JR Bradley JOURNAL OF PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started